Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares

Potential Lincoln Pharmaceuticals Limited (NSE:LINCOLN) shareholders may wish to note that the Whole Time Director, Munjal Patel, recently bought ₹30m worth of stock, paying ₹218 for each share. That's a very decent purchase to our minds and it grew their holding by a solid 15%.

View our latest analysis for Lincoln Pharmaceuticals

The Last 12 Months Of Insider Transactions At Lincoln Pharmaceuticals

Notably, that recent purchase by Munjal Patel is the biggest insider purchase of Lincoln Pharmaceuticals shares that we've seen in the last year. That implies that an insider found the current price of ₹220 per share to be enticing. That means they have been optimistic about the company in the past, though they may have changed their mind. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. The good news for Lincoln Pharmaceuticals share holders is that insiders were buying at near the current price.

Lincoln Pharmaceuticals insiders may have bought shares in the last year, but they didn't sell any. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Does Lincoln Pharmaceuticals Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Lincoln Pharmaceuticals insiders own about ₹2.0b worth of shares (which is 44% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

What Might The Insider Transactions At Lincoln Pharmaceuticals Tell Us?

It's certainly positive to see the recent insider purchases. And an analysis of the transactions over the last year also gives us confidence. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about Lincoln Pharmaceuticals. That's what I like to see! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Lincoln Pharmaceuticals. At Simply Wall St, we found 2 warning signs for Lincoln Pharmaceuticals that deserve your attention before buying any shares.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

When trading Lincoln Pharmaceuticals or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
^*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.